Original Research
Accepted on 25 Apr 2024
Sex Differences in Immune Protection in Mice Conferred by Heterologous Vaccines for Pneumonic Plague
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1397579
Type at least 3 characters
2,614 articles
Articles
Original Research
Published on 24 Apr 2024
A conserved motif in the immune-subdominant RAP-1 related antigen of Babesia bovis contains a B-cell epitope recognized by antibodies from protected cattle
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1380660
- 429 views
Methods
Published on 24 Apr 2024
Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1404121
- 528 views
Mini Review
Published on 23 Apr 2024
Maintenance of homeostasis by TLR4 ligands
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1286270
- 410 views
Original Research
Published on 22 Apr 2024
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1370564
- 738 views
Editorial
Published on 18 Apr 2024
Editorial: Precision vaccinology for infectious diseases
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1400443
- 374 views
Original Research
Published on 18 Apr 2024
Rapid generation of human recombinant monoclonal antibodies from antibody-secreting cells using ferrofluid-based technology
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1341389
- 682 views
Original Research
Published on 18 Apr 2024
Development of a nano-emulsion based multivalent protein subunit vaccine against Pseudomonas aeruginosa
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1372349
- 447 views
Clinical Trial
Published on 17 Apr 2024
Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1330178
- 436 views
Original Research
Published on 16 Apr 2024
Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1381508
- 937 views
Original Research
Published on 16 Apr 2024
Designing of a multi-epitopes based vaccine against Haemophilius parainfluenzae and its validation through integrated computational approaches
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1380732
- 850 views
Systematic Review
Published on 16 Apr 2024
Prevalence and genetic diversity of rotavirus among children under 5 years of age in China: a meta-analysis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1364429
- 366 views
Brief Research Report
Published on 12 Apr 2024
The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1340001
- 685 views
Opinion
Published on 11 Apr 2024
Unifying global efforts by CEPI’s centralized laboratory network
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1404309
- 414 views
Original Research
Published on 08 Apr 2024
Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1360220
- 812 views
Original Research
Published on 08 Apr 2024
Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1387534
- 666 views